Literature DB >> 19550327

Insulin resistance in women's health: why it matters and how to identify it.

Richard S Legro1.   

Abstract

PURPOSE OF REVIEW: To examine the significance of insulin resistance in women's health and review methods for diagnosing it. RECENT
FINDINGS: Clinical phenotypes in conjunction with standard clinical biochemical assays, that is, the metabolic syndrome, remain the key method to diagnose insulin resistance in clinical practice. Candidate alleles from type 2 diabetes offer little predictive value for cardiovascular events beyond traditional risk factors. Simple environmental factors such as irregular meal frequency appear to increase the risk of the metabolic syndrome and require greater scrutiny. Pregnancy complications, particularly gestational diabetes and preeclampsia in the mother and preterm birth in the fetus are events that suggest elevated risk for future cardiovascular morbidity in those affected.
SUMMARY: Clinical phenotypes of insulin resistance identify women at risk for perinatal and reproductive complications.

Entities:  

Mesh:

Year:  2009        PMID: 19550327      PMCID: PMC3590839          DOI: 10.1097/GCO.0b013e32832e07d5

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  43 in total

1.  Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

Authors:  Theodore P Ciaraldi; Vanita Aroda; Sunder Mudaliar; R Jeffrey Chang; Robert R Henry
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

2.  A history of preeclampsia identifies women who have underlying cardiovascular risk factors.

Authors:  Graeme N Smith; Mark C Walker; Aizhong Liu; Shi Wu Wen; Melissa Swansburg; Heather Ramshaw; Ruth Rennicks White; Michelle Roddy; Michelle Hladunewich
Journal:  Am J Obstet Gynecol       Date:  2008-08-08       Impact factor: 8.661

3.  Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.

Authors:  Sarah C Kent; Carol L Gnatuk; Allen R Kunselman; Laurence M Demers; Peter A Lee; Richard S Legro
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

4.  Metabolic profile in sons of women with polycystic ovary syndrome.

Authors:  Sergio E Recabarren; Rosita Smith; Rafael Rios; Manuel Maliqueo; Bárbara Echiburú; Ethel Codner; Fernando Cassorla; Pedro Rojas; Teresa Sir-Petermann
Journal:  J Clin Endocrinol Metab       Date:  2008-01-29       Impact factor: 5.958

5.  C-reactive protein is elevated 30 years after eclamptic pregnancy.

Authors:  Carl A Hubel; Robert W Powers; Sunna Snaedal; Hilary S Gammill; Roberta B Ness; James M Roberts; Reynir Arngrímsson
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

6.  Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (EarlyBird 36).

Authors:  Daphne S L Gardner; Joanne Hosking; Brad S Metcalf; Alison N Jeffery; Linda D Voss; Terence J Wilkin
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

7.  Genotype score in addition to common risk factors for prediction of type 2 diabetes.

Authors:  James B Meigs; Peter Shrader; Lisa M Sullivan; Jarred B McAteer; Caroline S Fox; Josée Dupuis; Alisa K Manning; Jose C Florez; Peter W F Wilson; Ralph B D'Agostino; L Adrienne Cupples
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

8.  Clinical risk factors, DNA variants, and the development of type 2 diabetes.

Authors:  Valeriya Lyssenko; Anna Jonsson; Peter Almgren; Nicoló Pulizzi; Bo Isomaa; Tiinamaija Tuomi; Göran Berglund; David Altshuler; Peter Nilsson; Leif Groop
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

9.  Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.

Authors:  Robert K Semple; Alison Sleigh; Peter R Murgatroyd; Claire A Adams; Les Bluck; Sarah Jackson; Alessandra Vottero; Dipak Kanabar; Valentine Charlton-Menys; Paul Durrington; Maria A Soos; T Adrian Carpenter; David J Lomas; Elaine K Cochran; Phillip Gorden; Stephen O'Rahilly; David B Savage
Journal:  J Clin Invest       Date:  2009-01-26       Impact factor: 14.808

10.  Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study.

Authors:  Trond M Michelsen; Are H Pripp; Serena Tonstad; Claes G Tropé; Anne Dørum
Journal:  Eur J Cancer       Date:  2008-11-12       Impact factor: 9.162

View more
  7 in total

1.  Diabetes prevention: Reproductive age women affected by insulin resistance.

Authors:  Shadi Rezai; Stephen LoBue; Cassandra E Henderson
Journal:  Womens Health (Lond)       Date:  2016-07

2.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

Review 3.  Vitamin D may be a link to black-white disparities in adverse birth outcomes.

Authors:  Lisa M Bodnar; Hyagriv N Simhan
Journal:  Obstet Gynecol Surv       Date:  2010-04       Impact factor: 2.347

4.  Similar and additive effects of ovariectomy and diabetes on insulin resistance and lipid metabolism.

Authors:  Shady H Tawfik; Bothaina F Mahmoud; Mohamed I Saad; Mona Shehata; Maher A Kamel; Madiha H Helmy
Journal:  Biochem Res Int       Date:  2015-03-05

5.  Periconceptional diet quality is associated with gestational diabetes risk and glucose concentrations among nulliparous gravidas.

Authors:  Karen L Lindsay; Gina F Milone; William A Grobman; David M Haas; Brian M Mercer; Hyagriv N Simhan; George R Saade; Robert M Silver; Judith H Chung
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-05       Impact factor: 6.055

6.  Preeclampsia as a risk factor for diabetes: a population-based cohort study.

Authors:  Denice S Feig; Baiju R Shah; Lorraine L Lipscombe; C Fangyun Wu; Joel G Ray; Julia Lowe; Jeremiah Hwee; Gillian L Booth
Journal:  PLoS Med       Date:  2013-04-16       Impact factor: 11.069

7.  Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus.

Authors:  Pawel Sadlecki; Marek Grabiec; Malgorzata Walentowicz-Sadlecka
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.